Bibliometric analysis of global research on breast cancer with HER2-low expression.

ABSTRACT:

Background

The abnormal expression of Human Epidermal Growth Factor Receptor 2 (HER2) is closely related to the prognosis of breast cancer. Since the concept of HER2-low expression was introduced in 2018, researches on HER2-low expression breast cancer have burgeoned. This bibliometric analysis seeks to evaluate the worldwide distribution of literature, research focuses, and upcoming trends in HER2-low expression breast cancer research.

Methods

We extensively searched for articles on HER2-low expression breast cancer from January 2018 to March 2025 using the Web of Science database. By employing the Bibliometrix, VOSviewer and CiteSpace, we systematically examined information regarding countries, institutions, authors, journals, and keywords.

Results

A total of 573 li

SUBMITTER: Zhu J 

PROVIDER: S-EPMC12748448 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature